Please login to the form below

Not currently logged in

AZ and Sutter Health enter cardiometabolic collaboration

Three-year partnership will design and pilot new treatments

AstraZeneca AZ headquarters London UK 

AstraZeneca has joined forces with not-for-profit organisation Sutter Health on a research and innovation collaboration on cardiometabolic healthcare.

The three-year partnership will work to design, prototype and pilot innovative approaches to the form of healthcare, which focuses on the treatment and management of diseases such as diabetes, hypertension and high cholesterol in addition to more common complications such as heart attack, blindness or death.

Greg Keenan, VP medical affairs and US medical officer at AZ, commented: “Diabetes, high blood pressure and poorly controlled cholesterol can have an enormous impact on a person's quality of life and the cost of healthcare.

“We believe that Sutter Health and AZ will bring together unique expertise and experiences to improve the lives of patients. 

“Through this innovative research collaboration, we hope to improve the future of cardiometabolic care and translate solutions into programmes that health systems nationwide could implement.”

Researchers will aim to help speed up diagnosis and improve the quality of life of patients by creating technologies and treatments through a better understanding of existing gaps in cardiometabolic care.

The collaboration will focus on three key areas; utilising key data from across the Sutter Health network into a electronic system and conduct novel analytical steps to identify gaps; personalising care by designing, developing and implementing new tools to help patients and providers work together; and supporting the continuous knowledge growth of researchers.

Article by
Kirstie Pickering

11th May 2015

From: Research, Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

When is it time to rebrand?
The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....